Naxions

Name

Naxions

Legal name

北京诺信创联科技有限公司

Website

https://naxions.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Marketing Technology

akta.pro primary industry

Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

• Virtual medical representatives
• Pharmaceutical marketing technology
• Medical information delivery
• AI pharma sales platform
• Grassroots doctor engagement

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Virtual Representative Services: Virtual representative services that help pharmaceutical companies reach grassroots doctors with medical information, enabling multi-product and multi-level hospital coverage

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Naxions provides AI-powered virtual representative services that enable pharmaceutical companies to deliver compliant medical information to grassroots doctors across China at scale. It sells an end-to-end solution combining standardized products, professional medical teams, and customer success services, supported by its self-developed Intelligent Business Operations Platform. The company serves 40+ pharmaceutical enterprises, covering 100+ drug products and reaching 300,000+ grassroots doctors.

Differentiator

Problem solved

Functional benefit

Products and services

• Virtual Representative (虚拟代表) AI-powered virtual sales representative service that enables pharmaceutical companies to reach and engage with grassroots doctors through digital channels. Designed for domestic and international pharma firms needing efficient, compliant, low-cost medical information transmission; covers 100+ drug products and 300,000+ grassroots doctors, with service drug market scale reaching 5 billion RMB.
• Intelligent Business Operations Platform (智能业务运营平台) Self-developed AI platform that supports pharmaceutical companies' core business operations, enabling compliant and efficient medical information delivery to healthcare professionals. Used by pharma companies as the underlying technology layer for the Virtual Representative service and broader medical information transmission workflows.

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Scale indicators4 records

Direct peers

• Aktana: Aktana provides AI-enabled decision support and commercial engagement tools for pharma, helping sales/marketing teams optimize physician interactions. Its AI-for-pharma-commercial model overlaps closely with Naxions' Virtual Representative offering.
• Veeva Systems: Veeva provides industry cloud/SaaS for life sciences, including CRM, medical, regulatory, and commercial engagement platforms used by global pharma. It is directly comparable to Naxions as a SaaS platform serving pharmaceutical companies' commercial and medical affairs workflows.
• Exeevo: Exeevo delivers CRM and engagement platforms tailored for life sciences companies, covering sales, medical, and service workflows. It overlaps with Naxions' intelligent operations platform approach to pharma commercial engagement.

Broad incumbents

• IQVIA: IQVIA is a large clinical and commercial services / health-data technology vendor to pharma, with AI-driven offerings that touch physician engagement, real-world data, and sales operations. It is directly comparable in the segment served and is also a disclosed Naxions investor (Series A in 2018).
• Salesforce (Life Sciences Cloud): Salesforce offers a Life Sciences Cloud and Health Cloud as part of a broader enterprise CRM portfolio. It competes for the same pharma commercial/CRM wallet that Naxions targets, though as a general-purpose platform rather than a pharma-native specialist.
• Microsoft Cloud for Healthcare: Microsoft's Cloud for Healthcare bundles data, AI, and engagement tools that overlap with pharma customer/physician engagement use cases. It represents an incumbent alternative for the same enterprise buyers Naxions serves.
• Syneos Health: Syneos Health combines clinical development and commercial services for pharma, with deployment of AI/data tooling into physician engagement. It is a broader incumbent compared to Naxions' narrower focus on virtual medical communications.

Others

• ZS Associates: ZS Associates is a management consulting and technology firm serving pharma, with practices in sales/marketing analytics and AI-driven commercial operations. It is adjacent to Naxions as a strategic partner or competing services provider for the same pharma commercial function.

Market position

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Naxions